224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study

Saved in:
Bibliographic Details
Published in:ESMO open 2023-05, Vol.8 (1), p.101413, Article 101413
Main Authors: Botticelli, A., Scagnoli, S., Pisegna, S., Santini, D., De Laurentiis, M., Caputo, R., Verrazzo, A., Scafetta, R., Orlandi, A., Palleschi, M., Alesini, D., Barberi, V., Fabbri, M.A., D'Auria, G., Strigari, L., Ballatore, Z., Tedesco, B., Preissner, R., Marchetti, P., Fabi, A.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2023.101413